The Neuroendocrine System and Gastrointestinal Complications in Patients with Familial Amyloidosis and Polyneuropathy

References

• Holmgren G, Holmberg E, Lindström A, Lindström E, Nordenson I, Sandgren O, et al. Familial amyloidotic polyneuropathy in Sweden by RFLP analysis. Clin Genet 1988; 33: 176–80
   PubMed Web of Science ®Google Scholar
• Andersson R. Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden. Acta Med Scand 1976; 198: 1–64, Suppl 590
   Google Scholar
• Holmgren G, Costa P, Andersson R, Asplund K, Steen L, Beckman L, et al. Geographical distribution of TTR met30 carriers in northern Sweden. Discrepancy between carriers frequency and prevalence rate. J Med Genet 1994; 31: 351–4
   PubMed Web of Science ®Google Scholar
• Saraiva M, Birkin S, Costa P, Goodman D. Amyloid fibril protein in familial amyloid polyneuropathy, Portugese type. Definition of molecular abnormality in transthyretin (prealbumin). J Clin Invest 1984; 74: 104–19
   PubMed Web of Science ®Google Scholar
• Tawara S, Nakazato M, Kangawa K, Matsuo H, Araki S. Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type). Biochem Biophys Res Commun 1983; 116: 880–8
   PubMed Web of Science ®Google Scholar
• Bhatia K, Reilly M, Adams D, Davis MB, Hawkes CH, Thomas PK, et al. Transthyretin mutations in British and French patients with amyloid neuropathy. J Neurol Neurosurg Psychiatry 1993; 56: 694
   PubMedGoogle Scholar
• Dwulet F, Benson M. Polymorphism of human plasma thyroxin binding prealbumin. Biochem Biophys Res Commun 1983; 114: 657–62
   PubMed Web of Science ®Google Scholar
• Staunton H, Dervan P, Kale R, Linke RP, Kelly P. Hereditary amyloid polyneuropathy in northwest Ireland. Brain 1987; 110: 1231–45
   PubMed Web of Science ®Google Scholar
• Chang CM, Yu YI, Wong M, Ng TH, Woo E, Haung CY. Type I familial amyloid polyneuropathy in Chinese family. Acta Neurol Scand 1989; 79: 391–6
   PubMed Web of Science ®Google Scholar
• Feurle G. Pathophysiology of diarrhoea in patients with familial amyloid neuropathy. Digestion 1987; 36: 13–7
   PubMed Web of Science ®Google Scholar
• Holt IJ, Harding AE, Middletton L, Chrysostomou G, Said G, King RH, et al. Molecular genetics of amyloid neuropathy in Europe. Lancet 1989; 1: 524–6
   PubMed Web of Science ®Google Scholar
• Olofsson B-O. Cardiac involvement in familial amyloidosis with polyneuropathy. Int J Cardiol 1983; 4: 71–3
   PubMed Web of Science ®Google Scholar
• Steen L, Ek B. Familial amyloidosis with polyneuropathy. Aspects of relationship between gastrointestinal symptoms. EMG findings, and malabsorption studies. Scand J Gastroenterol 1984; 19: 480–6
   PubMedGoogle Scholar
• Steen L, Ek B. Familial amyloidosis with polyneuropathy. A long term follow up of 21 patients with special reference to gastrointestinal symptoms. Acta Med Scand 1984; 214: 387–97
   Google Scholar
• Suhr O, Danielsson A, Steen L. Bile acid malabsorption caused by gastrointestinal motility dysfunction? An investigation of patients with familial amyloidosis with polyneuropathy. Scand J Gastroenterol 1992; 27: 201–7
   PubMed Web of Science ®Google Scholar
• Steen L. Gastrointestinal involvement in familial amyloidosis with polyneuropathy. A cliniccal study [thesis]. Umeå Faculty of Medicine. Umeå University. 1983; 93: 1–46
   Google Scholar
• Suhr O, Danielsson Å, Holmgren G, Steen L. Malnutrition and gastrointestinal dysfunction as a prognostic factors for survival in familial amyloidotic polneuropathy. J Intern Med 1994; 235: 479–85
   PubMed Web of Science ®Google Scholar
• Steen L, Öberg L. Familial amyloidosis with polyneuropathy. Roentgenologic and gastroscopic appearance of gastrointestinal involvement. Am J Gastroenterol 1983; 18: 961–8
   Google Scholar
• Monterio JG. The digestive system in familial amyloidotic polyneuropathy. Am J Gastroenterol 1973; 60: 47–59
   PubMedGoogle Scholar
• Ikeda S, Makishita H, Oguchi K, Yanagisawa N, Nagata T. Gastrointestinal amyloid deposition in familial amyloid polyneuropathy. Neurology 1982; 32: 1364–8
   PubMed Web of Science ®Google Scholar
• Ikeda S, Yanagisawa N, Hongo M, Ito N. Vagus nerve and celiac ganglion lesions in generalized amyloidosis. A correlative study of familial amyloid polyneuropathy and AL-amyloidosis. J Neurol Sci 1987; 79: 129–39
   PubMed Web of Science ®Google Scholar
• Takahashi K, Yi S, Kimura Y, Araki S. Familial amyloidotic polyneuropathy type 1 in Kumamoto, Japan. A clinicopatholo-gic, histochemical, immunohistochemical and ultrastructural study. Hum Pathol 1991; 22: 519–27
   PubMed Web of Science ®Google Scholar
• Hofer P-Å, Anderson R. Postmortem findings in familial amyloidosis with polyneuropathy, a study based on six cases from northern Sweden. Acta Pathol Microbiol Scand [A] 1975; 83: 309–22
   PubMedGoogle Scholar
• Rubenstein A, Yhar M, Mytileneou C, Bajaj K. Peripheral cathecholamin depletion in amyloid autonomic neuropathy. Sinai. J Med 1978; 45: 782–9
   Google Scholar
• El-Salhy M. On the phylogeny of the gastro-entro-pancreatic (GEP) neuroendocrine system. Acta Upsal 1981; 385: 1–39
   Google Scholar
• Dockary GJ, Walsh JH. Regulatory peptide systems of the gut, an introductory essay. Gut peptides biochemistry and physiology, GJ Dockary, JH Walsh. Raven Press, New York 1994; 1–10
   Google Scholar
• Debas TH, Mulvihill SJ. Neuroendocrine design of the gut. Am J Surg 1991; 161: 243–9
   PubMed Web of Science ®Google Scholar
• Ekblad E, Hakansson R, Sundler F. Microanatomy and chemical coding of peptides-containing neurone in the digestive tract. Neuropeptides function in gastrointestinal tract, E Daniel. CRC Press, Inc, Boston 1991; 131–80
   Google Scholar
• Harvey RF. Hormonal control of gastrointestinal motility. Am J Dig Dis 1975; 20: 523–39
   PubMedGoogle Scholar
• Allescher H, Ahmed S. Postulated physiological and pathophysiological roles on motility. Neuropeptides function in gastrointestinal tract, E Daniel. CRC Press Inc, Boston 1991; 309–400
   Google Scholar
• Mannon P, Taylor IL. The pancreatic polypeptide family. Gut peptides biochemistry and physiology, GJ Dockary, JH Walsh. Raven Press, New York 1994; 341–70
   Google Scholar
• Dockary GJ. Substance P and other tachykinins. Gut peptides biochemistry and physiology, GJ Dockary, JH Walsh. Raven Press, New York 1994; 401–22
   Google Scholar
• Dockary GJ. Vasoactive intestinal polypeptide and related peptides. Gut peptides biochemistry and physiology, GJ Dockary, JH Walsh. Raven Press, New York 1994; 447–72
   Google Scholar
• Qian B-F, Danielsson Å, El-Salhy M. Vagal regulation of the gastrointestinal system. Scand J Gastroenterol 1996; 31: 529–40
   PubMed Web of Science ®Google Scholar
• Sjölund K, Sandén G, Håkansson R, Sundler F. Endocrine cells in human intestine. An immunocytochemical study. Gastroenterology 1983; 85: 1120–30
   PubMed Web of Science ®Google Scholar
• Buchan A, Polak JM. The classification of the human gastro-enteropacreatic endocrine cells. Invest Cell Pathol 1980; 3: 51–71
   PubMedGoogle Scholar
• El-Salhy M, Grimelius L, Wilander E, Ryberg B, Terenius L, Lundberg JM, et al. Immunocytochemical identification of polypeptide YY (PYY) in the human gastrointestinal tract. Histochemistry 1983; 77: 15–23
   PubMedGoogle Scholar
• Qian B-F, El-Salhy M, Danielsson Å, Shalaby A, Axelsson H. The effect of unilateral vagotomy on antral endocrine cells in mouse. Histochem J 1997, in press
   Google Scholar
• El-Salhy M, Suhr O. Endocrine cells in rectal biopsy specimens from patients with familial amyloidotic polyneuropathy. Scand J Gastroenterol 1996; 31: 68–73
   PubMed Web of Science ®Google Scholar
• Huizinga JD, Pintin-Quezada J. Physiological and pathophy-siolgical roles of VIP, somatostatin, opioids, galanin, GRP, and secretin. Neuropeptides function in gastrointestinal tract, E Daniel. CRC Press Inc, Boston 1991; 401–28
   Google Scholar
• Jaffe JJ, Martin WR. Opioid analgesics and antagonists. Pharmacological basis of therapeutics, AG Gilman, LS Goodman, TW Rail, F Murad. Macmillan, New York 1985; 491–503
   Google Scholar
• Stewart JJ. Temporal effects of morphine on rat intestinal transit. Pharmacology 1984; 29: 47–54
   PubMedGoogle Scholar
• Plant OH, Miller GH. Effect of morphine and some other opium alkaloids on the muscular activity of the alimentary canal. J. Pharmacol Exp Ther 1926; 28: 245–52
   Google Scholar
• Blanquet F, Bouvier M, Conella J. Effects of enkephalins and morphine on spontaneous electrical activity and on junction potentials elicited by parasympathetic nerve stimulation in cat and rabbit colon. Br J Pharmacol 1982; 77: 419–26
   PubMed Web of Science ®Google Scholar
• Schang JC, Hemond M, Herbert M, Pilote M. How does morphine work on colonic motility? An electromyographic study in the human left and sigmoid colon. Life Sci 1986; 38: 671–5
   PubMedGoogle Scholar
• Adrian TE, Greenberg GR, Bloom SR. Actions of pancreatic polypeptide in man. Gut hormones, SR Bloom, JM Polak. Churchill Livingstone, Edinburgh 1981; 206–12
   Google Scholar
• McDonald TJ. Gastroentropancreatic regulatory peptide structure. An overview. Neuropeptides function in gastrointestinal tract, E Daniel. CRC Press Inc, Boston 1991; 19–86
   Google Scholar
• Lin TM, Evans DC, Shaar CJ, Chance RE. Physiological versus pharmacological actions of bovine pancreatic polypeptide on the pancreas, gallbladder, choledochal sphincter and intestine of dogs. Gut peptides, secretion, function, and clinical aspects, A Myoshi. Elsevier Biomedical Press, Amsterdam 1979; 175–81
   Google Scholar
• El-Salhy M, Suhr O, Stenling R, Wilander E, Grimelius L. Impact of familial amyloid associated polyneuropathy on duodenal endocrine cells. Gut 1994; 35: 1413–8
   PubMed Web of Science ®Google Scholar
• Steen L, Stenling R. The relatioship between morphological findings and function of the small intestine in familial amyloidosis with polyneuropathy. Scand J Gastroenterol 1983; 18: 961–8
   PubMed Web of Science ®Google Scholar
• Mulholand MW, Debas HT. Physiology and pathology of gastrin. A review. Surgery 1988; 103: 135–47
   PubMedGoogle Scholar
• Steen L, Holmgren G, Suhr O, Wikstrom L, Groth C-G, Ericzon B-G. World-wide survey of liver transplantation in patients with familial amyloidotic polyneuropathy. Amyloid Int Exp Clin Invest 1998; 1: 138–42
   Google Scholar
• Suhr O, Holmgren G, Ericzon B-G, Bromee U, Duraj F, Eleborg L, et al. Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients. Transplantation 1995; 60: 933–8
   PubMed Web of Science ®Google Scholar
• Ericzon B-G, Suhr O, Bromeé U, Holmgren G, Duraj F, Eleborg L, et al. Liver transplantation halts the progress of familial amyloidotic polyneuropathy. Transplantation Proc 1995; 27: 1233
   PubMed Web of Science ®Google Scholar
• Holmgren G, Ericzon B-G, Groh C-G, Steen L, Suhr O, Erson O, et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin anyloidosis. Lancet 1993; 341: 1113–6
   PubMed Web of Science ®Google Scholar